MedPath

A new dose-finding trial design to identify the optimal therapeutic dose of an upper limb intervention for people after stroke

Not Applicable
Completed
Conditions
Stroke
Circulatory System
Stroke, not specified as haemorrhage or infarction
Registration Number
ISRCTN23054430
Lead Sponsor
niversity of East Anglia (UK)
Brief Summary

1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28802774 (added 22/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
24
Inclusion Criteria

1. Aged 18+ years
2. Have presence of moderate upper limb paresis/impairment defined as participants able to open and close their paretic hand six times in one minute but unable to do this 25 times in one minute, from starting position of thumb and finger tips close with an extra, extra, light resistance band placed around fingers and thumb
3. Able to imitate action with the non­paretic upper limb. This will be assessed by the Research Therapist
4. Be discharged from stroke rehabilitation services

Exclusion Criteria

Participant should not receive therapy to improve upper limb motor function

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath